TRACK 1:
LIPOPROTEIN METABOLISM IN VIVO AND IN VITRO
HT1 |
| HOW TO USE LIPIDOMICS IN CARDIOVASCULAR DISEASE? |
| Chairpersons: |
J. Boren, Sweden
G. Schmitz, Germany
|
TRACK 2:
MOLECULAR GENETICS AND GENE-ENVIRONMENT INTERACTIONS
HT2 |
| HOW TO DESIGN PHARMACOGENETIC STUDIES USING CANDIDATE GENES? |
| Chairpersons: |
L. Masana, Spain
G.Siest, France |
TRACK 3:
CELL BIOLOGY AND METABOLISM OF ARTERIAL WALL
HT3 |
| HOW TO ANALYZE VASCULAR OXIDATIVE STRESS? |
| Chairpersons: |
M. Aviram, Israel
A. Ceriello, Italy |
TRACK 4:
RISK FACTORS, DIAGNOSIS AND TREATMENT
HT4 |
| HOW TO OPTIMIZE THE MANAGEMENT OF DYSLIPIDEMIA IN DIABETIC/INSULIN RESISTANT SUBJECTS? |
| Chairpersons: |
R. Carmena, Spain
S.M.Sadikot , India
|
